ADULTS WITH TYPE 2 DIABETES, ALONG WITH DIET AND EXERCISE
RETHINK THE MATH WHEN IT COMES TO A1c
GLYXAMBI can be used along with diet and exercise to improve blood sugar in adults with type 2 diabetes, and can be used in adults with type 2 diabetes who have known cardiovascular (CV) disease when empagliflozin (JARDIANCE), one of the medicines in GLYXAMBI, is needed to reduce the risk of cardiovascular death.
Dosing
Only GLYXAMBI combines the power of Jardiance® (empagliflozin) tablets and Trajenta® (linagliptin) tablets in a once-daily pill
Superior A1c reductions vs each individual component
10 mg empagliflozin 5 mg linagliptin 10/5 mg
The recommended dose for GLYXAMBI is 10 mg once daily, Glyxambi® can be taken regardless of food and time of the day1.
25 mg empagliflozin 5 mg linagliptin 25/5 mg
GLYXAMBI may be increased to 25 mg empagliflozin/5 mg linagliptin once daily for additional glycemic control
Assessment of renal function is recommended prior to initiation of GLYXAMBI.
Assess renal function before initiating GLYXAMBI and as clinically indicated
GLYXAMBI should be discontinued if eGFR is persistently less than 45 mL/min/1.73 m2
Reference
- Glyxambi® Singapore Prescribing Information.